Stemsation International, Inc. (STSN) Stock

About Stemsation International, Inc.

StemSation International, Inc., headquartered in Boca Raton, Florida, specializes in the development, manufacture, and distribution of natural wellness products. These offerings are specifically designed to bolster the human body's stem cell and endocannabinoid systems. Among its key products is StemRCM, a nutritional supplement created to enhance stem cells' natural capacity to mend, rejuvenate, and revitalize bodily tissues and organs. This is achieved by promoting healthy stem cell liberation, transport, and targeting within the system. The company markets its goods directly to consumers through a network of independent health advocates.

Stemsation International, Inc. is headquartered in US.

Stemsation International, Inc. (STSN) stock trades at $0.02 with a market capitalization of $1.50M. The stock is valued at a negative price-to-earnings (P/E) ratio of -24.55, reflecting a net loss over the last twelve months, price-to-book of 0.96, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.02, and currently trades at or near its 52-week high.

On profitability, Stemsation International, Inc. generates a return on equity (ROE) of -3.87% (negative, reflecting a net loss), return on capital employed of -3.36%.

Official website: www.stsninc.com